Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Critical RiskFDA Drug
Medications & Supplements/Prescription Drugs

Betaxolol Tablets Recalled for Potential Presence of Oxycodone Tablets

Agency Publication Date: October 18, 2023
Share:
Sign in to monitor this recall

Summary

KVK-Tech, Inc. has issued a voluntary recall for approximately 1,488 bottles of Betaxolol (10 mg) tablets, a medication used to treat high blood pressure. The recall was initiated because some bottles may accidentally contain Oxycodone HCl (5 mg) tablets, a powerful opioid pain reliever. No incidents or injuries have been reported to date. The affected medication was sold in 100-count bottles at pharmacies nationwide in the United States and Puerto Rico.

Risk

Taking oxycodone instead of the intended blood pressure medication could cause severe respiratory depression (slowed or stopped breathing), which can be fatal, especially for those who do not regularly take opioids. Additionally, missing a prescribed dose of betaxolol can lead to a sudden and dangerous increase in blood pressure.

What You Should Do

  1. This recall affects Betaxolol Tablets, USP 10 mg, sold in 100-count bottles (NDC 10702-013-01) with lot number 17853A and an expiration date of 06/30/2027.
  2. If you have health concerns or believe you have accidentally ingested the wrong medication, contact your healthcare provider or pharmacist immediately.
  3. Return any unused product to the place of purchase for a refund, throw it away, or contact KVK-Tech, Inc. for further instructions.
  4. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

💰Option 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
🗑️Option 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Betaxolol Tablets, USP 10 mg
Variants: 10 mg, 100 count bottles
Lot Numbers:
17853A (Exp. 06/30/2027)
NDC:
10702-013-01

Manufactured by KVK Tech Inc. in Newtown, PA.

Product Images

Image 1 “Betaxolol HCl Tablet, USP 10 mg”

Image 1 “Betaxolol HCl Tablet, USP 10 mg”

Image 2 “Oxycodone HCl Tablet, USP 5 mg”

Image 2 “Oxycodone HCl Tablet, USP 5 mg”

Image 3 “Front label, Betaxolol Tablets, USP 10 mg”

Image 3 “Front label, Betaxolol Tablets, USP 10 mg”

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 93101
Status: Resolved
Manufacturer: KVK-Tech, Inc.
Sold By: pharmacies
Manufactured In: United States
Units Affected: 1488 bottles
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · FDA Press Release · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.